Nisa Investment Advisors
XBIT icon

Nisa Investment Advisors’s XBiotech XBIT Stock Holding History

Nisa Investment Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-402
Closed -$1.3K – 3103
2025
Q1 		$1.3K Buy
402
+314
+357% +$1.08K ﹤0.01% 2572
2024
Q4 		$348 Hold
88
– – ﹤0.01% 2883
2024
Q3 		$680 Buy
+88
New +$578 ﹤0.01% 2662
2022
Q1 		– Sell
-3,000
Closed -$32K – 2409
2021
Q4 		$32K Sell
3,000
-1,000
-25% -$13K ﹤0.01% 1836
2021
Q3 		$52 Buy
+4,000
New +$63.7K ﹤0.01% 1926
2018
Q3 		– Sell
-24,800
Closed -$111K – 1986
2018
Q2 		$111K Hold
24,800
– – ﹤0.01% 1354
2018
Q1 		$133K Buy
24,800
+8,700
+54% +$40.1K ﹤0.01% 1310
2017
Q4 		$63K Buy
16,100
+2,400
+18% +$10.1K ﹤0.01% 1440
2017
Q3 		$60K Buy
+13,700
New +$64.7K ﹤0.01% 1435

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nisa Investment Advisors's XBIT Position: Q2 2025 in Review

Nisa Investment Advisors sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 402 shares — an estimated $1.3K sold.

Nisa Investment Advisors first reported a position in XBIT in Q3 2017 and held it in 9 quarters. The position peaked at $133K in Q1 2018. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • Nisa Investment Advisors reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 402 XBiotech shares in Q2 2025, an estimated $1.3K.
  • Nisa Investment Advisors first reported a position in XBiotech in Q3 2017 and held it in 9 quarters.
  • Nisa Investment Advisors's XBiotech position peaked at $133K in Q1 2018.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.